Alembic Pharmaceuticals Limited: Drug Recall
Recall #D-0459-2025 · 05/09/2025
Class II: Risk
Recall Details
- Recall Number
- D-0459-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Alembic Pharmaceuticals Limited
- Status
- Ongoing
- Date Initiated
- 05/09/2025
- Location
- Panchmahal, India
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,946 500-count bottles
Reason for Recall
Presence of Foreign Tablets/Capsules; customer complaint found one Tadalafil 5mg tablet inside a sealed 500-count bottle of Celecoxib 200mg capsule
Product Description
Celecoxib Capsules, 200 mg, 500-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division), Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-142-71
Distribution Pattern
Distributed Nationwide and in PR
Other Recalls by Alembic Pharmaceuticals Limited
- Class III: Low Risk 12/16/2025
- Class III: Low Risk 10/10/2025
- Class II: Risk 07/25/2025
- Class II: Risk 05/07/2025
- Class I: Dangerous 03/17/2021
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.